1-1 of 1
John Bernard
Close
Sort by
Journal Articles

Phase 1b Trial of Subcutaneous Epcoritamab in Pediatric Patients with Relapsed or Refractory (R/R) Aggressive Mature B-Cell Neoplasms (EPCORE Peds-1)

Mitchell S. Cairo, Mark A. Rocco, John Bernard, Satya R. Siddani, Apurvasena Parikh, Brian Elliott, Birgit Burkhardt
Journal: Blood
Blood (2022) 140 (Supplement 1): 3827–3828.
https://doi.org/10.1182/blood-2022-157546
Published: 2022